Company Profile

Caden Biosciences Inc (AKA: Cue Biotech)
Profile last edited on: 12/23/2014      CAGE: 3C019      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2000
First Award
2000
Latest Award
2005
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5500 Nobel Drive Suite 220
Madison, WI 53711
   (608) 278-8646
   Info@cadenbiosciences.com
   www.cadenbiosciences.com
Location: Single
Congr. District: 02
County: Dane

Public Profile

In August of 2008, it was reported that Caden Biosciences Inc was in the process of shutting down and liquidating its intellectual property. Caden Biosciences, Inc. operates as life sciences tools and services company which develops and markets assays for G-Protein Coupled Receptors. It develops assays and provides solutions to the pharmaceutical industry partners. The company was formerly known as Cue BIOtech, Inc. (under which it received its SBIR awards) and changed its name to Caden Biosciences, Inc. in August, 2006.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2005 2 NIH $849,428
Project Title: Antagonists of PAR1 - GQ Interaction
2003 1 NIH $203,578
Project Title: Identification of peptides specific for D5 receptor
2002 1 NIH $99,888
Project Title: Inhibitors of PAR1-G13 Interface for Arthersclerosis
2000 1 NIH $99,617
Project Title: Inhibitors Of Par-1 Gq Interface For Treatment Of ARDS

Key People / Management

  Annette F Gilchrist -- President

Company News

There are no news available.